
    
      -  In patients with Stage 2 hypertension to determine the efficacy and safety of
           Telmisartan/S-Amlodipine (80/2.5mg and 80/5mg) or S-Amlodipine monotherapy (2.5mg and
           5mg) during 8 weeks.

        -  This study is consist of placebo run-in period(2 weeks_single blind) and treatment
           period(8 weeks_double blind).
    
  